Research led by Dr. Philip Kern was highlighted by the National Institute of Diabetes and Digestive and Kidney Diseases.
LEXINGTON, Ky. (June 2, 2021) – Research led by University of Kentucky endocrinologist and Center for Clinical & Translational Science director Dr. Philip Kern was recently highlighted by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in its 2021 Recent Advances & Emerging Opportunities report. The publication conveys important accomplishments resulting from NIDDK-funded research, as well as the enormous promise this research holds for the future.
Kern’s research demonstrated for the first time that a medication called mirabegron, already FDA-approved to treat overactive bladder, improves multiple measures of glucose metabolism in people who are overweight/obese with insulin resistance by inducing beige fat formation in their white adipose fat tissue. The findings uncover a potential new mechanism for treatment of diabetes.
UKZNâs autumn graduation sees women excel as top achievers
By Brandstories
By Sithembile Shabangu and Indu Moodley
Of the 10 313 graduands awarded degrees and diplomas during the 2021 University of KwaZulu-Natal (UKZN) autumn virtual graduation ceremonies, 382 graduated cum laude and 149 summa cum laude - with women making up 68% of the top achievers.
The virtual graduation ceremonies were broadcast by the university between May 25 and 28.
Acting Executive Director of UKZNâs Corporate Relations Division, Normah Zondo said: âThe university had hoped that, by 2021, we would be able to hold our graduation celebrations the traditional way. Unfortunately, due to the unprecedented challenges brought about by Covid-19, the university has had, once again, to significantly change the manner in which it confers qualifications and distributes its degree and diploma certificates. As one of the largest universities in the country, this is an enormous undertaking.â